Reported about 5 hours ago
Moderna has announced the discontinuation of its experimental vaccine aimed at preventing cytomegalovirus, a leading cause of birth defects, after it failed to achieve its primary goal in a late-stage trial. The vaccine, tested on approximately 7,500 women aged 16 to 40, showed efficacy rates of only 6% to 23%, falling short of Moderna's expectations.
Source: YAHOO